2005年4月第7期
·07/05/08 Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche
·07/05/08 Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system
·07/05/08 Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial
·07/05/08 Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate
·07/05/08 Identification of Lin–Sca1+kit+CD34+Flt3– short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients
·07/05/08 In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis
·07/05/08 Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics
·07/05/08 BMP4 and Madh5 regulate the erythroid response to acute anemia
·07/05/08 Differential requirements for calcium and Src family kinases in platelet GPIIb/IIIa activation and thromboxane generation downstream of different G-protein pathways
·07/05/08 Hematopoietic cells regulate the angiogenic switch during tumorigenesis
·07/05/08 Tissue factor activity in whole blood
·07/05/08 The development of imatinib as a therapeutic agent for chronic myeloid leukemia
·07/05/08 VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly
·07/05/08 A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice
·07/05/08 Vessel wall–derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells
·07/05/08 Ly49Q defines 2 pDC subsets in mice
·07/05/08 Cell surface–associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein
·07/05/08 Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca2+-dependent association with annexin VI
·07/05/08 Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells
·07/05/08 Isolation and characterization of human antigen-specific TCR+ CD4-CD8- double-negative regulatory T cells
·07/05/08 Successful treatment of severe bleeding in hemophilic target joints by selective angiographic embolization
·07/05/08 CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells
·07/05/08 Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR
·07/05/08 Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation
·07/05/08 Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
·07/05/08 Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2
·07/05/08 CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-cell subset
·07/05/08 Abnormal interleukin-7 function in common variable immunodeficiency
·07/05/08 MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells
·07/05/08 Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11
·07/05/08 High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma
·07/05/08 Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity
·07/05/08 Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas
·07/05/08 Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas
·07/05/08 Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the μ and CD79a chains
·07/05/08 Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system
·07/05/08 Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial
·07/05/08 Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate
·07/05/08 Identification of Lin–Sca1+kit+CD34+Flt3– short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients
·07/05/08 In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis
·07/05/08 Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics
·07/05/08 BMP4 and Madh5 regulate the erythroid response to acute anemia
·07/05/08 Differential requirements for calcium and Src family kinases in platelet GPIIb/IIIa activation and thromboxane generation downstream of different G-protein pathways
·07/05/08 Hematopoietic cells regulate the angiogenic switch during tumorigenesis
·07/05/08 Tissue factor activity in whole blood
·07/05/08 The development of imatinib as a therapeutic agent for chronic myeloid leukemia
·07/05/08 VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly
·07/05/08 A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice
·07/05/08 Vessel wall–derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells
·07/05/08 Ly49Q defines 2 pDC subsets in mice
·07/05/08 Cell surface–associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein
·07/05/08 Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca2+-dependent association with annexin VI
·07/05/08 Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells
·07/05/08 Isolation and characterization of human antigen-specific TCR+ CD4-CD8- double-negative regulatory T cells
·07/05/08 Successful treatment of severe bleeding in hemophilic target joints by selective angiographic embolization
·07/05/08 CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells
·07/05/08 Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR
·07/05/08 Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation
·07/05/08 Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
·07/05/08 Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2
·07/05/08 CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-cell subset
·07/05/08 Abnormal interleukin-7 function in common variable immunodeficiency
·07/05/08 MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells
·07/05/08 Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11
·07/05/08 High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma
·07/05/08 Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity
·07/05/08 Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas
·07/05/08 Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas
·07/05/08 Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the μ and CD79a chains
栏目列表
·2005年7月第13期
·2005年7月第14期
·2005年8月第15期
·2005年8月第16期
·2005年9月第17期
·2006年1月第1期
·2006年1月第2期
·2006年2月第3期
·2004年1月第1期
·2004年1月第2期
·2004年2月第3期
·2004年2月第4期
·2005年1月第1期
·2005年1月第2期
·2005年2月第3期
·2005年2月第4期
·2005年3月第5期
·2005年3月第6期
·2005年4月第7期
·2005年4月第8期
·2005年5月第9期
·2005年5月第10期
·2005年6月第11期
·2005年6月第12期
·2006年2月第4期
·2006年3月第5期
·2006年3月第6期
·2006年4月第7期
·2006年4月第8期
·2006年5月第9期
·2006年5月第10期
·2006年6月第11期
·2006年6月第12期
·2006年7月第13期
·2006年7月第14期
·2005年7月第14期
·2005年8月第15期
·2005年8月第16期
·2005年9月第17期
·2006年1月第1期
·2006年1月第2期
·2006年2月第3期
·2004年1月第1期
·2004年1月第2期
·2004年2月第3期
·2004年2月第4期
·2005年1月第1期
·2005年1月第2期
·2005年2月第3期
·2005年2月第4期
·2005年3月第5期
·2005年3月第6期
·2005年4月第7期
·2005年4月第8期
·2005年5月第9期
·2005年5月第10期
·2005年6月第11期
·2005年6月第12期
·2006年2月第4期
·2006年3月第5期
·2006年3月第6期
·2006年4月第7期
·2006年4月第8期
·2006年5月第9期
·2006年5月第10期
·2006年6月第11期
·2006年6月第12期
·2006年7月第13期
·2006年7月第14期